Hereditary Cancer Syndromes
7
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Questionnaire on Congenital Cancer Signs Through Self-Assessment
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
Biomarker Monitoring in TP53 Mutation Carriers